Yanrong Liu
Tianjin Key Laboratory Of Molecular Drug Research
Tianjin, China
Tianjin, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Psychologic Stress Drives Progression of Malignant Tumors via DRD2/HIF1α Signaling.
Journal: Cancer research
Published: April 04, 2021
Potential type 2 diabetes mellitus drug HMPA promotes short-chain fatty acid production by improving carbon catabolite repression effect of gut microbiota.
Journal: British journal of pharmacology
Published: February 14, 2020
Glycyrrhizic Acid-Induced Differentiation Repressed Stemness in Hepatocellular Carcinoma by Targeting c-Jun N-Terminal Kinase 1.
Journal: Frontiers in oncology
Published: September 30, 2019
6-Gingerol stabilized the p-VEGFR2/VE-cadherin/β-catenin/actin complex promotes microvessel normalization and suppresses tumor progression.
Journal: Journal of experimental & clinical cancer research : CR
Published: March 23, 2019
Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
Journal: Journal for immunotherapy of cancer
Published: December 05, 2018
Antimalarial Drug Pyrimethamine Plays a Dual Role in Antitumor Proliferation and Metastasis through Targeting DHFR and TP.
Journal: Molecular cancer therapeutics
Published: August 16, 2018
Salvianolic acid A targeting the transgelin-actin complex to enhance vasoconstriction.
Journal: EBioMedicine
Published: August 11, 2018
Therapeutic effects of lentinan on inflammatory bowel disease and colitis-associated cancer.
Journal: Journal of cellular and molecular medicine
Published: June 25, 2018
Last Updated: 09/26/2026